Huntington's disease and related disorders

Psychiatric Clinics of North America

Volumn 28, Issue 1, 2005, Pages 275-290

  Anderson, Karen E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; CREATINE; DOPAMINE RECEPTOR BLOCKING AGENT; LAMOTRIGINE; MINOCYCLINE; PENICILLAMINE; PSYCHOTROPIC AGENT; REMACEMIDE; UBIDECARENONE;

ACANTHOCYTOSIS; CHOREA; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; DISEASE EXACERBATION; EXTRAPYRAMIDAL SYNDROME; GENETIC COUNSELING; HEREDITY; HUMAN; HUNTINGTON CHOREA; IMPULSE CONTROL DISORDER; LIVER DYSFUNCTION; MACHADO JOSEPH DISEASE; MENTAL DISEASE; MOTIVATION; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT; WILSON DISEASE;

EID: 14044274123     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2004.10.001     Document Type: Review

References (105)

1. G. Huntington On chorea Medical Surgical Reports 26 1872 320 321
2. S.E. Folstein, G.A. Chase, and W.E. Wahl Huntington's disease in Maryland: clinical aspects of racial variation Am J Hum Genet 41 1987 168 179
3. S.E. Folstein Huntington disease: a disorder of families 1st edition 1989 The Johns Hopkins Press Baltimore (MD)
4. J. Gilstad, and S.G. Reich Chorea in an octogenarian Neurologist 9 3 2003 165 166
5. I. Reuter, M.T.M. Hu, and T.C. Andrew Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome J Neurol Neurosurg Psychiatry 68 2000 238 241
6. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 1993 971 983
7. T.V. Strong, D.A. Tagle, and J.M. Valdes Widespread expression of the human and rat Huntington's disease gene in brain and non-neural tissues Nat Genet 5 1993 259 265
8. D. Rigamonti, J.H. Bauer, and C. De-Fraja Wild-type huntingtin protects form apoptosis upstream of caspase-3 J Neurosci 20 2000 3705 3713
9. M. Difiglia Excitotoxic injury of the neostriatum is a model for Huntington's disease Trends Neurosci 13 1990 286 289
10. M.F. Beal Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31 1992 119 130
11. F.C. Nucifora Jr., M. Sasaki, and M.F. Peters Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity Science 291 5512 2001 2423 2428
12. S.W. Davies, M. Turmaine, and B.A. Cozens Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for HD mutation Cell 90 1997 537 548
13. P. Ferrigno, and P.A. Silver Polyglutamine expansions: proteolysis, chaperones, and the dangers of promiscuity Neuron 26 2000 9 12
14. J.M. Ordway, S. Tallaksen-Greene, and C.A. Gutekunst Ectopically expressed CAG repeats caused intranuclear inclusions and a progressive late onset neurological phenotype in the mouse Cell 91 1997 753 763
15. M. Duyao, C. Ambrose, and R. Myers Trinucleotide repeat length instability and age of onset in Huntington's disease Nat Genet 4 1993 387 392
16. S. Furtado, O. Suchowersky, and N.B. Rewcastle The relationship of the trinucleotide repeat sequences and neuropathological changes in Huntington's disease Ann Neurol 39 1996 132 136
17. C. Zuhlke, O. Riess, and B. Bockel Mitotic stability and meiotic variability of the (CAG) n repeat in the Huntington disease gene Hum Mol Genet 2 1993 2063 2067
18. R.L. Margolis, E. O'Hearn, and A. Rosenblatt A disorder similar to Huntington's disease is associated with novel CAG repeat expansion Ann Neurol 50 2001 373 380
19. E.K. Richfield, J.P. Vonsattel, and M.E. MacDonald Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease Mov Disord 17 2002 327 332
20. G. Stevanin, A. Camuzat, and S.E. Holmes CAG/CTG repeat expansions at the Huntington's disease-like 2 locus are rare in Huntington's disease patients Neurol 58 2002 965 967
21. S. Hersch, R. Jones, and W. Koroshetz The neurogenetics genie: testing for the Huntington's disease mutation Neurology 44 1994 1369 1373
22. E.W. Almqvist, M. Bloch, and R. Brinkman A worldwide assessment of the frequency of suicide, suicide attempts or psychiatric hospitalization after predictive testing for Huntington disease Am J Hum Genet 64 1999 1293 1304
23. S.M. Hersch, and R.J. Ferrante Neuropathology and pathophysiology of Huntington's disease R.L. Watts W.C. Koller Movement disorders: neurologic principles and practice 1997 McGraw-Hill New York
24. J.C. Hedreen, and S.E. Folstein Early loss of neostriatal striosome neurons in Huntington's disease J Neuropathol Exp Neurol 54 1995 105 120
25. H.D. Rosas, J. Goodman, and Y.I. Chen Striatal volume loss in HD as measured by MRI and the influence of CAG repeat Neurology 57 2001 1025 1028
26. N. Turjanski, R. Weeks, and R. Dolan Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas: a PET study Brain 118 1995 689 696
27. N. Ginovart, A. Lundin, and L. Farde PET study of pre and postsynaptic dopaminergic markers for the neuordegenerative process in Huntington's disease Brain 120 1997 503 514
28. J.M. Vonsattel, R.H. Myers, and T.J. Stevens Neuropathological classification of Huntington's disease J Neuropathol Exp Neurol 44 1985 559 577
29. J.C. Hedreen, C.E. Peyser, and S.E. Folstein Neuronal loss in layers V and V1 of cerebral cortex in Huntington's disease Neurosci Lett 133 1991 257 261
30. R.C. Josiassen, L.M. Curry, and E.L. Mancall Development of neuropsychological deficits in Huntington's disease Arch Neurol 40 1983 791 796
31. J.R. Hodges, D.P. Salmon, and N. Butters Differential impairment of semantic and episodic memory in Alzheimer's and Huntington's diseases: a controlled prospective study J Neurol Neurosurg Psychiatry 53 1990 1089 1095
32. B. Pillon, B. Dubois, and F. Lhermitte Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease Neurology 36 1986 1179 1185
33. P.J. Massman, D.C. Delis, and N. Butters Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients J Clin Exp Neuropsychol 12 1990 729 744
34. B. Pillon, B. Dubois, and A. Ploska Severity and specificity of cognitive impairment in Alzheimer's, Huntington's and Parkinson's diseases and progressive supranuclear palsy Neurology 41 1991 634 643
35. H. Weingartner, E.D. Caine, and M.H. Ebert Imagery, encoding, and retrieval of information from memory: some specific encoding-retrieval changes in Huntington's disease J Abnorm Psychol 88 1979 52 58
36. N. Butters The clinical aspects of memory disorders: contributions from experimental studies of amnesia and dementia J Clin Neuropsychol 6 1984 17 36
37. N. Butters, D.P. Salmon, and C.M. Cullum Differentiation of amnesic and demented patients with the Wechsler Memory Scale-Revised Clin Neuropsychol 2 1988 133 148
38. B. Pillon, B. Deweer, and A. Michon Are explicit memory disorders of progressive supranuclear palsy related to damage to striato-frontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases Neurology 44 1994 1264 1270
39. C.R. Savage Neuropsychology of subcortical dementias Psychiatr Clin North Am 20 4 1997 911 931
40. R.S. Wilson, P.G. Como, and D.C. Garron Memory failure in Huntington's disease J Clin Exp Neuropsychol 9 1987 147 154
41. K.W. Lange, G.M. Paul, and T.W. Robbins L-DOPA and frontal cognitive function in Parkinson's disease Adv Neurol 60 1993 475 478
42. J. Brandt Cognitive impairments in Huntington's disease: insights into the neuropsychology of the striatum S. Corkin J. Grafman F. Boller Handbook of neuropsychology Volume 5 1991 Elsevier Amsterdam
43. K.W. Lange, B.J. Sahakian, and N.P. Quinn Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia J Neurol Neurosurg Psychiatry 58 1995 598 606
44. D. Knopman, and M.J. Nissen Procedural learning is impaired in Huntington's disease: evidence from the serial reaction time task Neuropsychologia 29 1991 245 254
45. Huntington Study Group Unified Huntington's disease rating scale: reliability and consistency Mov Disord 11 1996 136 142
46. B. Zappacosta, D. Monza, and C. Meoni Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease Arch Neurol 53 1996 493 497
47. M. Weigel-Weber, and W. Schmid Psychiatric symptoms and CAG expansion in Huntington's disease Am J Med Genet 67 1996 53 57
48. J.L. Cummings Behavioral and psychiatric symptoms associated with Huntington's disease W.J. Weiner A.E. Lang Behavioral neurology of movement disorders 1995 Raven Press New York 179 186
49. J.S. Paulsen, R.E. Ready, and J.M. Hamilton Neuropsychiatric aspects of Huntington's disease J Neurol Neurosurg Psychiatry 71 3 2001 310 314
50. J.C. Thompson, J.S. Snowden, and D. Craufurd Behavior in Huntington's disease: dissociating cognition-based and mood-based changes J Neuropsychiatry Clin Neurosci 14 2002 1 37-43
51. K.E. Anderson, and K.S. Marder An overview of psychiatric symptoms in Huntington's disease Curr Psychiatry Rep 3 2001 379 388
52. S. Pflanz, J.A.O. Besson, and K.P. Ebmeier The clinical manifestation of mental disorder in Huntington's disease: a retrospective case record study of disease progression Acta Psychiatr Scand 83 1991 53 60
53. K. Marder, H. Zhao, and R.H. Myers Rate of functional decline in Huntington's disease. Huntington Study Group Neurology 54 2 2000 452 458
54. M.A. Nance, and G. Sanders Characteristics of individuals with Huntington disease in long-term care Mov Disord 11 5 1996 542 548
55. J.S. Paulsen, N. Butter, and J.R. Sadek Distinct cognitive profiles of cortical and subcortical dementia in advanced illness Neurology 45 1995 951 956
56. M.L. Levy, J.L. Cummings, and L.A. Fairbanks Apathy is not depression J Neuropsychiatry Clin Neurosci 10 1998 314 319
57. H.S. Mayberg, S.E. Starkstein, and C.E. Peyser Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease Neurology 42 9 1992 1791 1797
58. L.A. Farrer Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk Am J Med Genet 24 2 1986 305 311
59. M.F. Mendez Huntington's disease: update and review of neuropsychiatric aspects Int J Psychiatry Med 24 1994 189 208
60. K. Dewhurst, J.E. Oliver, and A.L. McKnight Socio-psychiatric consequences of Huntington's disease Br J Psychiatry 116 1970 255 258
61. K.E. Anderson, E.D. Louis, and Y. Stern Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease Am J Psychiatry 158 5 2001 799 801
62. C. Benkelfat, T.E. Nordahl, and W.E. Semple Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine Arch Gen Psych 47 9 1990 840 848
63. D.C. Cath, P. Spinhoven, and T.C. van Woerkom Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: which symptoms discriminate? J Nerv Ment Dis 189 4 2001 219 228
64. D. Laplane, M. Levasseur, and B. Pillon Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study Brain 112 1989 699 725
65. S.E. Swedo, H.L. Leonard, and M. Garvey Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases Am J Psych 155 2 1998 264 271
66. P. Jensen, S.A. Sorenson, and K. Fenger A study of psychiatric morbidity in patients with Huntington's disease, their relatives, and controls: admissions to psychiatric hospitals in Denmark from 1969-1991 Br J Psychiatry 163 1993 790 797
67. M. SuttonBrown, and O. Suchowerdky Clinical and research advances in Huntington's disease Can J Neurol Sci 30 Suppl 1 2003 S45 S52
68. R.J. Ferrante, O.A. Andreassen, and B.G. Jenkins Neuroprotective effects of creatine in transgenic mouse model of Huntington's disease J Neurosci 20 2000 4389 4397
69. O.A. Andreassen, A. Dedeoglu, and R.J. Ferrante Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease Neurobiol Dis 8 3 2001 479 491
70. M. Chen Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease Nat Med 6 2000 797 801
71. Huntington Study Group A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease Neurology 57 2001 397 404
72. B. Kremer, C.M. Clark, and E.W. Almqvist Influence of lamotrigine on progression of early Huntington's disease: a randomized clinical trial Neurology 53 1999 1000 1011
73. A.E. Harding The clinical features and classification of the late onset autosomal dominant cerebellar ataxias: a study of 11 families, including descendants of the Drew family of Walworth Brain 105 1982 1 28
74. G. Campanella, A. Filla, and G. De Michele Classifications of hereditary ataxias: a critical overview Acta Neurol 14 1992 408 419
75. R.L. Margolis The spinocerebellar ataxias: order emerges from chaos Curr Neurol Neurosci Rep 2 2002 447 456
76. C.A. Ross Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders Neuron 35 5 2002 819 822
77. E. Tan, and T. Ashizawa Genetic testing in spinocerebellar ataxias: defining a clinical role Arch Neurol 58 2001 191 195
78. V.G.H. Evidente, K.A. Gwinn-Hardy, J.N. Caviness, and S. Gilman Hereditary ataxias Mayo Clin Proc 75 2000 475 490
79. A. Durr, G. Stevanin, and G. Cancel Spinocerebellar ataxia 3 and Machad-Joseph disease: clinical, molecular, and neuropathological features Ann Neurol 39 1996 490 499
80. I. Leroi, E. O'Hearn, and L. Marsh Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease Am J Psychiatry 159 2002 1306 1314
81. S.J. Kish, M. El-Awar, and D. Stuss Neuropsychological test performance in patients with dominantly inherited spinocerebellar ataxia: relationship to ataxia severity Neurology 44 1994 1738 1746
82. A.J. Berman Amelioration of aggression: response to selective cerebellar lesions in the rhesus monkey Int Rev Neurobiol 41 1997 111 119
83. M. Liotti, H.S. Mayberg, and S.K. Brannan Differential limbic-cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders Biol Psychiatry 48 2000 30 42
84. H. Skre A study of certain traits accompanying some inherited neurological disorders Clin Genet 8 1975 117 135
85. M. Reilly, L. Daly, and M. Hutchinson An epidemiological study of Wilson's disease in the Republic of Ireland J Neurol Neurosurg Psychiatry 56 3 1993 298 300
86. H. Roelofsen, H. Wolters, and M.J. Van Luyn Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for billiary copper excretion Gastroenterology 119 2000 782 793
87. W. Oder, G. Grimm, and H. Kollegger Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases J Neurol 238 2001 281 287
88. E.C. Lauterbach Wilson's disease (hepatolenticular degeneration) E.C. Lauterbach Psychiatric management in neurological disease 2000 American Psychiatric Press Washington (DC) 93 136
89. M. Akil, and G.J. Brewer Psychiatric and behavioral abnormalities in Wilson's disease Adv Neurol 65 1995 171 178
90. T.R. Denning, and G.E. Berrios Wilson's disease: a longitudinal study of psychiatric symptoms Biol Psychiatry 28 1990 255 265
91. J.M. Walshe Penicillamine: the treatment of first choice for patients with Wilson's disease Mov Disord 14 4 1999 545 550
92. G.J. Brewer Penicillamine should not be used as initial therapy in Wilson's disease Mov Disord 14 4 1999 551 554
93. G. Arendt, H. Hefter, and W. Stremmel The diagnostic value of multi-modality evoked potentials in Wilson's disease Eltromyogr Clin Neurophysiol 34 1994 137 148
94. E.C. Lauterbach Wilson's disease Psychiatr Ann 32 2002 114 120
95. M. Akil, J.A. Schwartz, and D. Dutchak The psychiatric presentations of Wilson's disease J Neuropsychiatry Clin Neurosci 3 4 1991 377 382
96. E.C. Lauterbach, J.L. Cummings, and J. Duffy Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases J Neuropsychiatry Clin Neurosci 10 1998 249 266
97. L. Rampoldi, A. Danek, and A.P. Monaco Clinical features and molecular bases of neuroacanthocytosis J Mol Med 80 2002 475 491
98. R.J. Hardie, H.W. Pullon, and A.E. Harding Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases Brain 114 1991 13 49
99. M.C. Spitz, J. Jankovic, and J.M. Killian Familial tic disorder, Parkinsonism, motor neurone disease, and acanthocytosis: a new syndrome Neurology 35 1985 366 370
100. A. Danek, J.P. Rubio, and L. Rampoldi McLeod neuroacanthocytosis: genotype and phenotype Ann Neurol 50 2001 755 764
101. L. Rampoldi, C. Dobson-Stone, and J.P. Rubio A conserved sorting-associated protein is mutant in chorea-acanthocytosis Nat Genet 28 2 2001 119 120
102. L.D. Kartsounis, and R.J. Hardie The pattern of cognitive impairments in neuroacanthocytosis Arch Neurol 53 1996 77 80
103. A. Danek, M. Tierney, and L. Sheesley Cognitive findings in patients with chorea-acanthocytosis Mov Disord 16 2001 S30
104. J.P. Kane, and R.J. Havel Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins C.R. Scrivner A.L. Beaudet W.S. Sly The metabolic bases of inherited disease 7th edition 1995 McGraw-Hill New York 1853 1885
105. D.T. Dexter, D.J. Brooks, and A.E. Harding Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studies Ann Neurol 35 1994 298 303